Cargando…
Limitations of a 6-min walk test to assess the efficacy of menthol for breathlessness
l-Menthol is a novel treatment option for breathlessness in patients with COPD. However, the clinical application of menthol for the treatment of exertional breathlessness in these patients warrants further research. https://bit.ly/3D6rLiJ
Autores principales: | Kanezaki, Masashi, Ebihara, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081546/ https://www.ncbi.nlm.nih.gov/pubmed/35539436 http://dx.doi.org/10.1183/23120541.00090-2022 |
Ejemplares similares
-
L-Menthol Olfactory Stimulation Reduced Dyspnea Sensation during the 6 min Walk Test in Patients with Chronic Breathlessness Syndrome: A Pilot Study
por: Sato, Naofumi, et al.
Publicado: (2023) -
The use of menthol for breathlessness: a hot topic full of fresh ideas
por: Prieur, Guillaume, et al.
Publicado: (2022) -
The modified Borg/6-min walk distance ratio: a method to assess exertional breathlessness and leg discomfort using the 6-min walk test
por: Ekström, Magnus, et al.
Publicado: (2023) -
Weight-based reference equations for the 6-min walk test can be misleading in obese patients
por: Haynes, Jeffrey M., et al.
Publicado: (2020) -
Effect of facial skin cooling induced by a handheld fan on the cough reflex threshold and urge to cough induced by citric acid
por: Kanezaki, Masashi, et al.
Publicado: (2019)